Literature DB >> 8712794

Differential diagnosis and management of Cushing's syndrome.

C Tsigos1, G P Chrousos.   

Abstract

The diagnosis of endogenous Cushing's syndrome requires demonstration of an increased cortisol secretion rate, best achieved by urinary free cortisol excretion determinations. In borderline or confusing cases, loss of diurnal cortisol rhythmicity, a combined dexamethasone/corticotropin releasing hormone (CRH) test, or close monitoring of the patient for a few months will be helpful in ruling out pseudo-Cushing's. Primary adrenal Cushing's syndrome can be ruled out on the basis of a normal or elevated basal and/or CRH-stimulated plasma adrenocorticotropin (ACTH) and a negative adrenal computed tomography. ACTH-dependent Cushing's syndrome can then be differentiated on the basis of a CRH test and imaging procedures. A discrete pituitary lesion on magnetic resonance imaging and a standard CRH test with results consistent with such a lesion are sufficient to proceed to transsphenoidal surgery. If no discrete pituitary lesion is present, or if the CRH test is equivocal, bilateral simultaneous inferior petrosal sinus sampling with CRH administration is necessary to distinguish between a pituitary and an ectopic source. Surgery is the treatment of choice for all types of Cushing's syndrome. In the few cases in which transsphenoidal surgery fails or the disease recurs, repeat transsphenoidal surgery, or radiation therapy in association with mitotane treatment, is a reasonable alternative. Bilateral adrenalectomy effectively cures hypercortisolism if resection of the ACTH-secreting tumor is unsuccessful and radiation/medical therapy fails.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8712794     DOI: 10.1146/annurev.med.47.1.443

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  14 in total

1.  Decreased glucose tolerance and plasma adiponectin:resistin ratio in a mouse model of post-traumatic stress disorder.

Authors:  T R Castañeda; R Nogueiras; T D Müller; R Krishna; E Grant; A Jones; N Ottaway; G Ananthakrishnan; P T Pfluger; N Chaudhary; M B Solomon; S C Woods; J P Herman; M H Tschöp
Journal:  Diabetologia       Date:  2010-12-22       Impact factor: 10.122

Review 2.  Neonatal Cushing Syndrome: A Rare but Potentially Devastating Disease.

Authors:  Christina Tatsi; Constantine A Stratakis
Journal:  Clin Perinatol       Date:  2017-12-12       Impact factor: 3.430

Review 3.  Are BDNF and glucocorticoid activities calibrated?

Authors:  F Jeanneteau; M V Chao
Journal:  Neuroscience       Date:  2012-09-26       Impact factor: 3.590

4.  Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.

Authors:  R Görges; G Knappe; H Gerl; M Ventz; F Stahl
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

5.  Cost-effectiveness and accuracy of the tests used in the differential diagnosis of Cushing's syndrome.

Authors:  J Puig; A Wägner; A Caballero; J Rodríguez-Espinosa; S M Webb
Journal:  Pituitary       Date:  1999       Impact factor: 4.107

Review 6.  Cushing syndrome in pediatrics.

Authors:  Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2012-09-27       Impact factor: 4.741

7.  Psychosocial morbidity in Cushing disease: a study from India.

Authors:  Surendra Kumar Mattoo; Anil Kumar Bhansali; Nitin Gupta; Sandeep Grover; Rama Malhotra
Journal:  Endocrine       Date:  2009-04-09       Impact factor: 3.633

8.  Facial Plethora: Modern Technology for Quantifying an Ancient Clinical Sign and Its Use in Cushing Syndrome.

Authors:  Ali Afshari; Yasaman Ardeshirpour; Maya Beth Lodish; Evgenia Gourgari; Ninet Sinaii; Margaret Keil; Elena Belyavskaya; Charalampos Lyssikatos; Fatima A Chowdhry; Victor Chernomordik; Afrouz A Anderson; Thomas A Mazzuchi; Amir Gandjbakhche; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2015-08-24       Impact factor: 5.958

9.  The relation of thyroid function to components of the metabolic syndrome in Korean men and women.

Authors:  Sat Byul Park; Ho Chun Choi; Nam Seok Joo
Journal:  J Korean Med Sci       Date:  2011-03-28       Impact factor: 2.153

10.  The effect of ketoconazole on post-burn inflammation, hypermetabolism and clinical outcomes.

Authors:  Marc G Jeschke; Felicia N Williams; Celeste C Finnerty; Noe A Rodriguez; Gabriela A Kulp; Arny Ferrando; William B Norbury; Oscar E Suman; Robert Kraft; Ludwik K Branski; Ahmed M Al-mousawi; David N Herndon
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.